Boston and San Francisco are two of the most important technology centers in the United States, but their AI startup ecosystems are not simply smaller and larger versions of the same thing. They are developing in very different ways, attracting different kinds of founders, producing different kinds of companies, and rewarding different startup strategies.
San Francisco is now operating at a scale that is difficult for any other American startup market to match. Capital, AI talent, frontier model companies, venture firms, founders, and fast-growing enterprise AI startups are packed into one ecosystem. In 2026, that concentration has become even stronger.
Boston has a different advantage. Its AI ecosystem is deeply connected to universities, scientific research, biotechnology, health care, robotics, engineering, and industries where software has to work with difficult real-world data. Boston has less capital flowing through its startup market, but it has an unusually strong system for turning technical research into specialized companies.
That distinction matters.
A founder building the next general-purpose AI developer platform may experience San Francisco very differently from a founder building AI for clinical trials, protein design, industrial robotics, or medical diagnostics. An investor searching for fast-moving application software may also approach the two markets differently from an investor looking for technically difficult companies with long-term intellectual property.
To understand what is actually happening, BostonBizScene analyzed the latest publicly available data from PitchBook and the National Venture Capital Association, Carta, CBRE, Startup Genome, government programs, universities, and individual AI companies.
The result is a much more useful picture than simply asking whether Boston or San Francisco is the “better” AI city.
The Short Version: San Francisco Has the AI Capital Machine, While Boston Has the Research-to-Industry Machine
San Francisco’s biggest advantage is concentration.
Capital is concentrated there. AI specialists are concentrated there. Frontier model companies are concentrated there. Venture firms are close to founders, founders are close to other founders, and many startups are returning to dense office environments where recruiting, fundraising, hiring, and product development can happen within the same network.
Boston has less of that density, but it has another form of concentration: technical institutions and industries where advanced AI can solve expensive problems.
MIT, Harvard, hospitals, biotechnology companies, pharmaceutical companies, engineering organizations, robotics labs, and a large scientific workforce give Greater Boston a particularly strong foundation for applied AI. The Massachusetts government is also making direct investments in AI compute and commercialization infrastructure.
The numbers show the difference clearly.
| Metric | San Francisco Bay Area | Greater Boston | What It Suggests |
| Q2 2026 VC deal value | $98.6B | $5.1B | San Francisco operates at dramatically larger capital scale |
| Q2 2026 VC deal count | 761 | 202 | Boston still has substantial startup activity |
| Implied capital per deal* | $129.6M | $25.2M | Bay Area capital is far more concentrated into large financings |
| AI-skilled workers, June 2026 | 98,699 | 27,494 | San Francisco has about 3.6× Boston’s AI talent |
| AI share of local tech talent | 26% | 17% | AI is more concentrated inside San Francisco’s technology workforce |
| Average tech-industry wage | $211,048 | $141,703 | San Francisco talent is roughly 49% more expensive |
| 2025 share of Carta startup funding | 41.3% | 6.6% | San Francisco dominates broad venture fundraising |
| 2025 share of U.S. AI fundraising on Carta | 53.4% | roughly 3%–4% | San Francisco over-indexes heavily in AI funding |
| 2025 share of U.S. biotech fundraising on Carta | — | 26.2% | Boston massively over-indexes in biotechnology |
| AI office leasing since 2019 | 21M sq. ft. across SF + Silicon Valley | 3.7M sq. ft. | Both are real physical AI clusters, but Bay Area scale is much larger |
*BostonBizScene calculation: total quarterly deal value divided by total quarterly deal count. This is a capital-intensity indicator, not the median financing round.
PitchBook-NVCA data shows 761 Bay Area venture deals representing $98.6 billion during Q2 2026, compared with 202 Boston-area deals totaling $5.1 billion. CBRE counted 98,699 AI-specialty workers in the Bay Area and 27,494 in Boston by June 2026. Carta’s 2025 data also shows the Bay Area capturing 41.3% of startup capital raised on its platform and 53.4% of AI funding, while Boston captured 6.6% of overall funding but 26.2% of biotechnology funding.
That leads to the central finding of this analysis:
San Francisco is becoming the place where AI capital, software talent, and fast-scaling AI companies compound together. Boston is becoming one of the strongest places to connect AI with science, health care, biotechnology, engineering, and other difficult industries.
Those are very different startup engines.
How BostonBizScene Conducted This Analysis
Comparisons between technology ecosystems often fail because they mix different geographic definitions, different years, and different kinds of data.
A city-level comparison is particularly misleading here. Many important Boston companies are technically located in Cambridge, Somerville, Watertown, or other nearby communities. Similarly, many companies associated with the San Francisco ecosystem sit in Silicon Valley communities outside the City of San Francisco.
For that reason, this analysis uses the broader startup ecosystems whenever the underlying source does the same.
The Geographic Definitions
“Boston” in this article generally means the Greater Boston startup and technology ecosystem.
“San Francisco” generally means the San Francisco Bay Area, including Silicon Valley when the source combines the region.
That is more useful for founders because talent, investors, universities, customers, and companies cross municipal borders constantly.
The Main Public Data Sources
| Source | Data Used |
| PitchBook-NVCA Venture Monitor | Venture deal counts and deal values |
| Carta | Geographic fundraising shares and sector concentration |
| CBRE Scoring Tech Talent 2026 | AI employment, AI concentration, wages and talent rankings |
| CBRE Tech Gateway Office Markets | AI office leasing and physical clustering |
| Startup Genome GSER 2026 | Ecosystem scale and global positioning |
| Massachusetts government | AI Hub and compute infrastructure investments |
| MIT and Harvard | Research and AI infrastructure |
| Company announcements | Funding and operating examples from individual startups |
The comparison uses the newest comparable data available as of September 24, 2026.
What Is Original About the Analysis?
The underlying datasets are public. The calculations and comparisons below are BostonBizScene’s analysis.
We calculate year-over-year changes in venture activity, capital-per-deal ratios, capital concentration differences, talent ratios, wage differences, funding specialization indexes, and several cross-market relationships that are not presented directly in the source reports.
That is important because a raw number such as “$98.6 billion invested in the Bay Area” does not explain how the startup machine works.
The relationships between the numbers tell us much more.
Original Finding #1: San Francisco Had 19 Times Boston’s Venture Deal Value in Q2 2026, but Only 3.8 Times the Number of Deals
This may be the single most important number in the entire comparison.
During Q2 2026, the Bay Area recorded approximately $98.6 billion of venture deal value across 761 deals. Boston recorded approximately $5.1 billion across 202 deals.
The difference in deal count is significant.
The difference in capital is extraordinary.
Chart: Q2 2026 Venture Capital
DEAL VALUE
San Francisco Bay Area $98.6B ███████████████████████████████████████
Boston $5.1B ██
DEAL COUNT
San Francisco Bay Area 761 ██████████████████████████████████████
Boston 202 ██████████
San Francisco had about 3.77 times as many venture deals, but it attracted approximately 19.33 times as much capital.
That tells us the Bay Area advantage is not just about having more startups.
It is about the size of the checks being written.
The Capital-Intensity Gap Is Enormous
Divide total deal value by deal count and another pattern appears.
| Q2 2026 | Bay Area | Boston |
| Deal value | $98.6B | $5.1B |
| Deal count | 761 | 202 |
| Deal value ÷ deal count | $129.6M | $25.2M |
Again, this should not be interpreted as the average startup receiving exactly those amounts. Quarter-level investment totals are heavily affected by giant financings.
That distortion is actually the point.
The Bay Area’s ecosystem increasingly contains companies capable of absorbing billions or tens of billions of dollars.
The ratio of capital value per reported deal was approximately 5.1 times higher in the Bay Area.
The modern San Francisco AI economy is therefore not simply producing startups. It is producing an unusually large number of companies that investors are willing to finance at enormous scale.
Original Finding #2: Boston’s Deal Count Is Growing Faster, but San Francisco’s Dollars Are Growing Much Faster
Comparing Q2 2025 with Q2 2026 makes the difference even more interesting.
PitchBook-NVCA reported roughly 664 Bay Area venture deals worth $35 billion in Q2 2025. Boston recorded 164 deals worth $2.7 billion.
One year later, the Bay Area reached 761 deals and $98.6 billion, while Boston reached 202 deals and $5.1 billion.
BostonBizScene calculated the year-over-year changes.
| Metric | Bay Area Growth | Boston Growth |
| Deal count | +14.6% | +23.2% |
| Deal value | +181.7% | +88.9% |
| Capital per reported deal | $52.7M → $129.6M | $16.5M → $25.2M |
This produces one of the most useful findings in the analysis.
Boston Is Showing Breadth
Boston’s deal count grew faster than San Francisco’s.
A 23.2% increase in deals is meaningful because it suggests startup formation and financing activity were not limited to one or two giant companies.
The ecosystem appears to be widening.
San Francisco Is Showing Extreme Capital Concentration
San Francisco’s deal value increased almost 182%.
Its deal count increased less than 15%.
That means the giant rise in capital cannot be explained simply by more companies raising money. Much of it came from dramatically larger financing events.
This fits the wider U.S. venture market. The official Q2 2026 PitchBook-NVCA Venture Monitor says AI companies and financings of $100 million or more were responsible for an overwhelming share of invested capital, while investment remained highly concentrated.
The same report found that AI represented 86% of U.S. venture deal value during the first half of 2026 even though AI accounted for a much smaller share of total deal count.
That matters enormously for understanding San Francisco.
The city is sitting at the center of the part of venture capital receiving the largest checks.
Original Finding #3: San Francisco Over-Indexes in AI Funding, While Boston Over-Indexes Almost Four Times in Biotech
Carta provides another useful way to compare the markets.
For startups on Carta, Bay Area companies captured 41.3% of U.S. startup capital raised in 2025. Boston captured 6.6%.
That means the Bay Area’s broad startup funding share was approximately 6.3 times Boston’s.
Now look specifically at AI.
San Francisco captured 53.4% of AI fundraising on Carta.
Boston’s share was between approximately 3% and 4%.
Chart: Share of U.S. Startup Fundraising on Carta, 2025
ALL STARTUP FUNDING
Bay Area 41.3% █████████████████████████████████████████
Boston 6.6% ███████
AI FUNDING
Bay Area 53.4% █████████████████████████████████████████████████████
Boston ~3–4% ████
BOSTON BIOTECH FUNDING
Boston 26.2% ██████████████████████████
Here is where our own specialization calculation becomes useful.
The BostonBizScene Funding Specialization Index
We divided each ecosystem’s share of funding in a sector by its share of all startup funding.
A value above 1.0 means the market attracts a larger share of that sector’s capital than its overall venture footprint would suggest.
For San Francisco AI:
53.4% AI share ÷ 41.3% overall share = 1.29
San Francisco therefore attracted roughly 29% more AI funding than we would expect from its already enormous overall venture share.
Boston tells almost the opposite story in general AI funding.
Using Carta’s reported 3%–4% range:
3%–4% AI share ÷ 6.6% overall share = 0.45–0.61
Boston therefore under-indexed in broad AI fundraising relative to its overall venture market.
But now look at biotechnology.
26.2% biotech share ÷ 6.6% overall share = 3.97
Boston’s share of biotechnology funding was approximately four times larger than its overall share of venture funding would suggest.
That is an extraordinary specialization.
Why This Matters for AI
AI is increasingly moving into biology.
The line between an “AI startup” and a “biotechnology startup” is becoming less useful when companies are using machine learning to design proteins, discover drugs, interpret biological information, optimize clinical trials, or automate scientific experimentation.
Boston may therefore look smaller if AI is measured mainly as software.
It looks much more strategically important when AI is measured as intelligence applied to science.
That is a major difference between Boston and San Francisco.
Original Finding #4: San Francisco Has 3.6 Times the AI Talent, but That Talent Is Almost 49% More Expensive
Capital gets most of the attention, but startups are built by people.
CBRE’s 2026 Scoring Tech Talent report provides one of the clearest current pictures of AI talent concentration.
By June 2026, the San Francisco Bay Area had approximately 98,699 workers with AI-specialty skills.
Boston had approximately 27,494.
Chart: AI-Specialty Talent, June 2026
San Francisco Bay Area 98,699 ███████████████████████████████████████
Boston 27,494 ███████████
San Francisco therefore had about 3.59 times Boston’s AI-specialty workforce.
That gap is large, but it is far smaller than the 19.3-times difference in Q2 venture capital.
That produces another useful insight.
Boston has much more AI talent relative to its current venture capital flow than the headline funding numbers might suggest.
AI Is Also More Concentrated Inside San Francisco’s Tech Workforce
CBRE found that approximately 26% of Bay Area tech talent had AI-specialty skills.
Boston was at approximately 17%.
Both figures are high.
But San Francisco’s number shows just how deeply AI has moved into the local technology labor market.
More than one in four tech workers in CBRE’s measurement had relevant AI skills.
The Cost Difference Is Also Large
CBRE reported average annual tech-industry wages of $211,048 in the San Francisco Bay Area and $141,703 in Boston.
BostonBizScene calculates that the Bay Area figure is approximately 48.9% higher.
Viewed from the other direction, Boston’s average was approximately 32.9% lower.
| Talent Metric | Bay Area | Boston | Difference |
| AI-specialty workers | 98,699 | 27,494 | SF 3.59× larger |
| AI concentration | 26% | 17% | SF +9 percentage points |
| Avg. tech-industry wage | $211,048 | $141,703 | SF +48.9% |
| CBRE 2026 tech-talent ranking | #1 | #7 | Both top-tier markets |
CBRE ranked San Francisco first among North American tech talent markets in 2026. Boston rose two positions to seventh.
This creates a real strategic trade-off for founders.
San Francisco provides a much larger pool of AI-specialized people, but competition for those people is severe and compensation expectations are extremely high.
Boston provides a smaller pool, but it remains one of North America’s deepest technical labor markets and can be materially less expensive.
The Talent Difference Is About Type, Not Just Quantity
There is another layer that raw headcount misses.
San Francisco has an enormous concentration of people who have already worked inside venture-backed software companies.
A startup can hire engineers who understand scaling cloud products, developer tools, consumer products, AI infrastructure, foundation models, enterprise sales, usage-based pricing, and venture-backed hypergrowth.
That experience compounds.
A person can leave one AI company on Friday and join another one a few blocks away.
Boston’s talent system is different.
It has unusually strong connections between computer science, biology, medicine, engineering, robotics, pharmaceutical research, hospitals, and universities.
For a company solving a technical problem that requires deep domain knowledge, that mixture can be more important than having the largest possible number of general software engineers.
Boston’s University Pipeline Is a Different Kind of Competitive Advantage
Boston’s greatest long-term strength may not be the companies currently raising money.
It may be the institutions continually producing new ideas and technical talent.
MIT reported more than $2.2 billion in sponsored research spending during fiscal 2025, representing 43% of its operating expenditures.
Harvard’s Kempner Institute has also expanded its AI computing infrastructure significantly. Its expanded cluster includes 424 Nvidia H200 GPUs, 384 H100 GPUs, 144 A100 GPUs, and 192 RTX Pro 6000 Blackwell GPUs, bringing the total to 1,144 GPUs.
That matters because AI entrepreneurship increasingly starts with access to compute, research talent, and specialized datasets.
Boston Produces More Tech Graduates Than Its Local Market Absorbs
CBRE’s education analysis has repeatedly identified Boston as one of North America’s largest producers of technology graduates.
Its 2025 report placed Boston among the markets producing the highest number of tech-related bachelor’s and advanced degrees. It also identified Boston as a net education market, meaning local institutions were producing more tech graduates than local tech-job creation was absorbing.
That could be viewed as a weakness.
It can also be viewed as unrealized startup supply.
If more graduates can be pulled directly into local company formation, Boston has room to convert more of its educational advantage into startup growth.
Massachusetts Is Building AI Infrastructure Around Its Existing Research Strength
Massachusetts has also started treating AI infrastructure as economic infrastructure.
The state’s FY2026-FY2030 capital plan includes approximately $68.6 million for the Massachusetts AI Hub.
A separate $31 million state grant was announced to develop artificial intelligence compute resources at the Massachusetts Green High Performance Computing Center. The goal is to give universities, startups, businesses, and other participants access to computing and data infrastructure that would otherwise be difficult for smaller organizations to obtain.
In May 2026, Massachusetts also opened applications for an AI startup accelerator created with IBM and Red Hat.
The direction is important.
Boston is not trying to recreate San Francisco’s ecosystem company by company.
Its emerging strategy is much more closely connected to applied AI, university research, life sciences, health care, climate technology, and computing infrastructure.
San Francisco’s Competitive Advantage Is the Speed of the Entire AI Loop
Boston has powerful individual ingredients.
San Francisco’s advantage is that almost all of its ingredients sit inside the same rapidly moving loop.
An engineer leaves a frontier model company.
They meet a potential co-founder.
A venture investor introduces them to another technical founder.
They hire several engineers from nearby startups.
Early customers are already experimenting with AI.
Another investor leads the next round.
Employees from the new company eventually leave and start companies of their own.
The process repeats.
This is how clusters compound.
Startup Genome’s 2026 analysis illustrates the scale. Silicon Valley remained the world’s number-one startup ecosystem and reached an estimated ecosystem value above $3 trillion. Its AI-native ecosystem value reached approximately $611 billion, representing a 263% increase from Startup Genome’s earlier comparison period.
Boston ranked third among North American ecosystems in Startup Genome’s 2026 regional rankings, behind Silicon Valley and New York.
Boston remains an elite global startup market.
San Francisco is simply operating at another scale.
The Company Mix Explains the Difference Better Than Any Ranking
Look at the companies emerging from the two markets and the distinction becomes much easier to understand.
San Francisco Is Producing Giant AI Platforms and Application Companies
Anthropic announced a $30 billion Series G in February 2026 at a $380 billion post-money valuation.
Sierra, which builds AI agents for customer service and enterprise customer experiences, raised $950 million in May 2026 at a valuation above $15 billion.
Legal AI company Harvey raised another $550 million in September 2026 at a $15.5 billion valuation after announcing a $200 million financing at an $11 billion valuation only months earlier. Harvey says 80% of the Am Law 100 now use its technology.
These are not tiny experimental companies anymore.
They are rapidly becoming major software platforms.
The Bay Area Can Fund Scaling Before Most Markets Can Match the Pace
This is one reason San Francisco’s aggregate venture numbers have become so extreme.
When a handful of AI businesses can raise hundreds of millions or billions of dollars, ecosystem-level investment totals become radically different from cities where the average venture-backed company is raising a more traditional Series A or Series B.
That does not necessarily mean every San Francisco startup has easier access to capital.
It means the ecosystem contains more companies sitting in the part of the funding distribution where extraordinary sums are being deployed.
Boston’s Most Interesting AI Companies Look Different
Boston’s emerging AI companies often sit closer to a specific industry, scientific field, or operational workflow.
That can make them less visible in broad conversations about chatbots and general-purpose AI.
It can also create stronger barriers to competition.
Lila Sciences Shows the Scale of Scientific AI
Lila Sciences announced the completion of a $350 million Series A in October 2025, taking total capital raised to $550 million.
The company is building what it calls AI Science Factories, combining AI with automated experimentation to accelerate scientific discovery.
This is a very Boston-style AI company.
The product is not simply software placed on top of an API.
AI is being connected directly to scientific experimentation.
Liquid AI Shows Boston Can Build Foundational Technology Too
Cambridge-based Liquid AI emerged from MIT research and develops a different approach to foundation models.
Its $250 million Series A in late 2024 valued the company around $1 billion.
This is important because Boston should not be reduced to “AI for biotech.”
The region can still produce core AI architecture.
The difference is that Boston’s strongest structural advantage appears when advanced computing intersects with other difficult fields.
Basis Shows Enterprise Agents Can Scale From Boston
Basis announced a $100 million Series B in February 2026 at a $1.15 billion valuation.
The company is focused on AI agents for accounting work, including reconciliations, accounting memos, journal entries, and complex tax workflows.
Accounting is a good example of where Boston could become more competitive with San Francisco.
It is technically demanding enterprise work with clear economic value, but it does not require the company to build a frontier foundation model.
Health AI Is Becoming a Real Boston Cluster
Boston-based VideaHealth raised $40 million in 2025 to expand its dental AI platform.
Overjet, another Boston dental AI company, previously raised $53.2 million in a Series C, bringing reported funding at the time to roughly $133 million. Its platform works with both dental providers and insurance organizations.
Two significant dental AI companies emerging in the same ecosystem is not random.
Boston contains deep medical expertise, health care institutions, technical universities, insurers, and clinicians.
That creates exactly the environment where narrow health AI categories can become surprisingly large.
AI-Native Biotechnology May Become Boston’s Most Defensible Category
Generate Biomedicines may be an even stronger example.
The Somerville company uses machine learning and large-scale biological experimentation to design proteins.
Generate completed an IPO in 2026 after raising more than $750 million privately, according to the company.
The company says its platform has generated, built, and tested tens of thousands of proteins.
A startup like this demonstrates why simple comparisons of “number of AI SaaS companies” can underestimate Boston.
Software is part of the product.
Biology is part of the product.
Experimental infrastructure is part of the product.
Clinical development is part of the company.
That is a fundamentally different startup model.
Original Finding #5: San Francisco’s Physical AI Cluster Is More Than Five Times Boston’s
There was a period when technology ecosystems appeared to be becoming permanently remote.
AI is pushing in the opposite direction.
CBRE reports that AI-related companies have leased approximately 21 million square feet of office space across San Francisco and Silicon Valley since 2019.
Boston recorded approximately 3.7 million square feet.
BostonBizScene calculates that the Bay Area figure is approximately 5.7 times larger.
Chart: AI Company Office Leasing Since 2019
San Francisco + Silicon Valley 21.0M sq. ft. ██████████████████████████████████████
Boston 3.7M sq. ft. ███████
CBRE also reported that San Francisco and Silicon Valley together accounted for about 66% of AI office leasing across the six largest markets it analyzed.
This matters beyond commercial real estate.
Office leasing is a signal of ecosystem behavior.
Many high-growth AI companies want employees physically near each other.
San Francisco Is Becoming Dense Again
AI and technology companies leased more than 14 million square feet across San Francisco and Silicon Valley during 2025, representing about 55% of total leasing activity in those markets.
OpenAI alone has built a major Mission Bay footprint, with reports in September 2026 indicating its occupied or planned space in that neighborhood could exceed 1.1 million square feet.
This physical density creates another feedback loop.
Workers meet other workers.
Founders meet investors.
Customers visit startups.
Employees leave mature AI companies and launch new ones.
The ecosystem becomes faster.
Boston’s Density Is More Distributed Across Different Worlds
Boston is geographically compact, but its innovation network is more fragmented by industry.
A founder may spend one day near MIT in Cambridge, another meeting a pharmaceutical company, another visiting a hospital, and another talking to an investor downtown.
That sounds like a small difference.
It changes how startup networks form.
San Francisco increasingly has one giant AI conversation.
Boston has several overlapping conversations: AI, biotech, medicine, robotics, universities, enterprise technology, defense, scientific computing, and climate technology.
The opportunity is to connect them more aggressively.
Boston vs. San Francisco for a Founder: The Answer Depends on What You Are Building
The most useful question is not, “Which city is better?”
It is:
Which ecosystem gives this particular company an unfair advantage?
If You Are Building a Frontier Model Company
San Francisco offers the deepest combination of specialized AI engineers, model researchers, infrastructure talent, investors willing to finance extraordinary compute costs, and people who have already worked inside frontier AI labs.
CBRE says the Bay Area contains almost 99,000 AI-skilled workers, while Startup Genome describes Silicon Valley as structurally different from other startup ecosystems because of its enormous value, capital base, and AI-native concentration.
For a company competing directly at the foundation-model layer, those advantages are difficult to ignore.
If You Are Building General Enterprise AI
San Francisco also has a strong advantage.
Sierra and Harvey demonstrate how quickly an enterprise AI company can move from early adoption to giant financing rounds and multibillion-dollar valuations.
The ecosystem contains enterprise software founders, product leaders, engineers, sales executives, and investors who understand that growth model.
Boston can absolutely produce enterprise AI companies, as Basis demonstrates.
But the surrounding network is smaller.
If You Are Building AI for Biotechnology
Boston’s case becomes much stronger.
Carta’s data shows Boston capturing 26.2% of U.S. biotech funding on its platform during 2025, nearly four times what its general venture share would predict.
The ecosystem combines capital, labs, pharmaceutical companies, universities, biology talent, and AI researchers.
For a company that needs wet-lab infrastructure as much as GPUs, that combination is highly valuable.
If You Are Building AI for Health Care
Boston again has structural advantages.
The region contains research hospitals, clinicians, health care researchers, medical schools, insurers, startups, and investors with long experience evaluating health technology.
Companies such as VideaHealth and Overjet show how specialized medical AI categories can grow from the ecosystem.
The challenge is that health care moves more slowly than consumer software.
The benefit is that once a company solves regulatory, clinical, workflow, and data problems, those same difficulties can become barriers to new competitors.
If You Are Building AI for Scientific Discovery
Boston may have one of the strongest cases anywhere.
Lila Sciences, Generate Biomedicines, the Kempner Institute’s computing infrastructure, MIT research, and Massachusetts’ investments in shared AI compute all point toward the same opportunity.
This could become one of Boston’s defining AI categories.
If You Are Building an AI Consumer App
San Francisco likely offers a more natural surrounding ecosystem.
The Bay Area has a larger concentration of product engineers, growth talent, consumer software experience, venture capital, and other founders experimenting with new interfaces.
Boston has consumer technology companies, but that is not where its strongest AI advantage appears today.
A Practical Founder Decision Matrix
| Startup Type | Boston’s Structural Advantage | San Francisco’s Structural Advantage |
| Frontier foundation models | MIT research, technical talent | Massive AI talent pool, compute financing, frontier-lab network |
| Developer tools | Strong engineering universities | Very dense developer/startup customer base |
| Enterprise agents | Domain-heavy industries and lower talent cost | Enterprise AI capital, talent and scaling experience |
| Health AI | Hospitals, clinicians, research institutions | Capital and engineering scale |
| Biotech AI | Exceptional life-sciences cluster | Large pools of AI capital |
| Drug discovery | Biology + AI + lab infrastructure | AI talent and investors |
| Robotics | MIT and engineering depth | Software, capital and adjacent autonomy talent |
| Financial AI | Strong enterprise talent | Larger fintech/AI founder network |
| Legal AI | Strong professional-services market | Mature category leaders and venture network |
| Consumer AI | Smaller advantage | Large founder, growth and product ecosystem |
This table should not be interpreted as saying a company must be created in one place.
Modern startups can hire nationally and globally.
But headquarters still matters because the earliest employees, investors, design partners, advisers, and founder relationships often come from the local network.
Boston’s Lower Talent Cost Is More Important Than It Looks
It is easy to say that San Francisco is expensive.
The strategic point is more specific.
A nearly 49% difference in average tech-industry wages can materially change how long a venture round lasts.
Imagine two technically similar companies building teams with dozens of highly skilled employees.
Even if the Boston company still pays premium salaries, a lower surrounding labor market can reduce pressure on every hiring decision.
That can be especially useful for deep-tech companies where research and development may continue for years before revenue becomes large.
But Founders Should Not Optimize Only for Payroll
Cheaper labor does not automatically mean cheaper company building.
If a San Francisco company can hire the exact engineer it needs in one week while a Boston company searches for three months, the lower salary may not matter.
If the Bay Area company can raise the next financing round faster, capital availability can overwhelm salary differences.
Location strategy must therefore be based on total execution speed, not simply compensation.
For Investors, Boston and San Francisco Require Different Search Strategies
An investor walking through the San Francisco AI market can find a huge number of companies attacking horizontal software categories.
AI coding.
AI customer support.
AI legal work.
AI sales.
AI assistants.
AI infrastructure.
AI developer tools.
AI research systems.
AI security.
The market is fast, crowded, and expensive.
Boston Requires More Domain Work
Some of Boston’s most interesting AI companies may not initially look like conventional AI startups.
They may call themselves biotechnology companies.
Medical technology companies.
Robotics companies.
Scientific software companies.
Industrial companies.
Clinical-trial platforms.
The AI can sit deep inside the product rather than on the homepage.
Investors evaluating Boston therefore need more domain knowledge.
They may need to understand biology, clinical development, manufacturing, regulation, or engineering.
That creates more work.
It can also create opportunities that are less obvious.
Original Finding #6: Boston Has an AI Commercialization Gap, Not an AI Research Gap
The data leads to an important conclusion for the Boston ecosystem.
Boston does not appear to suffer from a shortage of advanced technical people.
CBRE counted more than 27,000 AI-skilled workers in the region. Boston also ranks among the largest technology-education markets in North America.
The gap appears further downstream.
Boston has a much smaller share of AI startup funding than its educational, scientific, and technical capabilities might suggest.
That implies the region’s biggest opportunity may be commercialization.
In simple terms:
Boston already knows how to produce research.
It needs to become even better at turning that research into rapidly growing AI companies.
Universities Need More Founder Pathways
Technical researchers should have clearer paths from laboratory work into company formation.
That means easier access to startup advisers, early customers, experienced operators, venture investors, and entrepreneurial peers.
MIT already produces many startups.
The opportunity is to make company creation feel normal across an even larger portion of Boston’s research network.
More Experienced AI Operators Need to Recycle Into New Companies
One major reason Silicon Valley compounds is that successful companies continually produce future founders.
Employees learn how startups scale.
They make money.
They build relationships.
Then some leave and start again.
Boston needs more of this recycling cycle in AI.
Companies such as Liquid AI, Basis, Lila Sciences, VideaHealth, Overjet and other current Boston AI businesses could eventually produce dozens of future founders.
That second generation may matter as much as today’s companies.
San Francisco Has the Opposite Problem: Extreme Concentration Creates Its Own Risks
San Francisco’s strengths are obvious.
Its weaknesses increasingly come from the same source.
Capital is extraordinarily concentrated.
Talent is expensive.
Competition for engineers is intense.
Startup valuations can become detached from what companies in other markets would receive.
The PitchBook-NVCA data is especially revealing. In 2025, the San Jose-San Francisco-Oakland region accounted for 52.4% of total U.S. venture deal value while representing 22.3% of deal count.
That is not normal geographic concentration.
It means a huge amount of U.S. startup wealth creation is now riding on one region and a relatively small number of giant companies.
For individual founders, this environment can be both powerful and unforgiving.
The AI Funding Boom Is Also Changing What Counts as a Competitive Startup
Historically, many startups competed primarily through product quality, distribution, and execution.
AI adds another major variable:
capital.
Frontier model development is expensive.
Inference can be expensive.
Recruiting world-class researchers is expensive.
Large enterprise deployments require infrastructure and support.
The financial strength of an ecosystem therefore matters more in AI than it did for many traditional SaaS companies.
San Francisco is benefiting enormously from this change.
CBRE estimates that U.S.-based AI startups raised about $578 billion in venture capital between 2020 and Q1 2026, with roughly 80% flowing to the San Francisco Bay Area.
That level of concentration creates capabilities that are difficult to copy.
But Falling AI Costs Could Help Boston
The other side of the story is that not every future AI company will need to build a giant model.
Inference costs continue to fall.
Open models continue improving.
Smaller models are becoming more capable.
Stanford’s AI Index has documented major declines in the cost of achieving a given level of model performance. Its 2025 report found that the cost of querying a model performing around the GPT-3.5 level on one benchmark fell from roughly $20 per million tokens in late 2022 to about $0.07 by late 2024.
That trend changes startup geography.
If powerful models become cheaper commodities, the competitive advantage moves upward.
Who has the proprietary workflow?
Who has the data?
Who understands the customer?
Who can connect AI to a real operational system?
Who can prove the result?
Those questions play directly into Boston’s strengths.
Enterprise AI Could Narrow Part of the Gap
The next wave of AI may not be won only by companies with the biggest models.
Enterprise adoption is moving toward AI that can perform complete workflows.
That includes accounting agents, clinical research agents, scientific agents, customer-service agents, coding agents, and many others.
Stanford’s 2026 AI Index reports that organizational AI adoption continued rising in 2025, while agent adoption remained relatively early across most business functions.
That means there is still an enormous amount of market formation ahead.
Boston does not need to beat San Francisco at producing generic AI companies.
It can produce agents that understand specialized industries better than general systems do.
Where Boston Can Build the Strongest AI Moats
The most attractive Boston AI categories share several features.
The customer has expensive problems.
Data is difficult.
Domain knowledge matters.
Mistakes have consequences.
Workflows are complicated.
The buyer values accuracy more than novelty.
Integration matters.
Regulation or scientific validation creates friction.
Those conditions make it difficult for a generic AI wrapper to win simply by shipping quickly.
Health Care
AI companies can work on clinical documentation, diagnostics, medical imaging, patient operations, revenue cycles, insurance, drug development, trial design, or hospital workflows.
Boston already has customers and technical expertise nearby.
Biotechnology
This is perhaps the clearest category.
AI can change molecule discovery, proteins, biological simulation, laboratory automation, clinical development, and research operations.
Boston already owns an unusually large share of America’s life-sciences startup ecosystem.
Robotics
Robotics requires software, hardware, controls, engineering, sensing, and physical-world testing.
Those capabilities fit Boston’s university and engineering base particularly well.
Industrial and Scientific AI
Manufacturing, laboratories, materials research, climate technology, aerospace, and engineering all require combinations of AI and domain knowledge.
These categories receive less consumer attention than chatbots.
They may create extremely valuable companies.
Where San Francisco’s Moats Are Hardest to Challenge
San Francisco’s strongest advantages appear in categories where network density and capital velocity matter most.
Frontier AI
Training major models requires tremendous capital, specialized researchers, infrastructure relationships, and increasingly complicated hardware planning.
San Francisco already contains much of that system.
Developer Infrastructure
AI startups frequently sell to other AI startups.
When customers, engineers, investors, and partners are physically concentrated, developer infrastructure companies can learn extremely quickly.
Horizontal Enterprise Software
Companies selling across many industries benefit from the Bay Area’s enterprise SaaS experience.
There is already a large population of people who know how to build, sell, price, and scale enterprise software.
Consumer AI
Consumer products depend on rapid product iteration, growth expertise, design, and talent willing to experiment with new interfaces.
San Francisco has a very large concentration of that experience.
The Most Interesting Future May Be Boston and San Francisco Working Together
The ecosystems do not operate in isolation.
A Boston biotechnology AI company may raise money from a San Francisco venture fund.
A San Francisco software company may sell into Boston hospitals.
A Boston researcher may join a Bay Area startup.
A San Francisco company may open a research operation near MIT.
The best companies can combine the strengths of both places.
A Boston Headquarters With Bay Area Capital
For a deeply scientific company, headquarters near Boston’s laboratories and universities can make sense while investor relationships remain national.
There is no rule saying Boston companies must raise Boston money.
Lila Sciences, for example, attracted a broad national and international investor base for its large financing.
A Bay Area Headquarters With Boston Research
The reverse structure can also work.
A software-heavy company can maintain its main commercial and engineering organization in San Francisco while building partnerships with Boston universities, hospitals, pharmaceutical companies, or research institutions.
AI increasingly makes these cross-ecosystem models normal.
What Boston Business Leaders Should Do With This Information
Boston companies evaluating AI vendors should pay attention to the geographic specialization.
For general-purpose AI infrastructure, developer products, horizontal enterprise agents, and frontier models, many of the strongest vendors will continue emerging from the Bay Area.
For health care, biotechnology, scientific AI, robotics, and specialized enterprise systems, local Boston companies deserve serious attention.
The more important lesson is that businesses should not buy AI based on where the vendor is located.
They should buy based on workflow performance.
Measure Completed Work
An AI product should be measured by outcomes such as cases completed, research time reduced, claims processed, experiments accelerated, tickets resolved, errors prevented, or revenue generated.
The interface matters less than the operational result.
Use Boston’s Proximity as an Advantage
Boston businesses have access to universities, startups, accelerators, hospitals, laboratories, and technical talent.
Local firms should test products earlier.
Becoming a design partner can create an advantage before a technology becomes widely available.
That is one of the most underused benefits of operating inside an innovation ecosystem.
What Boston Founders Should Learn From San Francisco
Boston should not copy San Francisco completely.
It should copy specific behaviors that work.
Build Faster Commercial Feedback Loops
Technical depth can become a weakness when teams spend too long perfecting a product before customers use it.
San Francisco’s strongest companies tend to put software in front of customers quickly.
Boston deep-tech founders should borrow that urgency without lowering scientific standards.
Make Ambition Visible
Boston startups can sometimes communicate like research projects.
San Francisco startups often communicate like they intend to own a category.
Good marketing cannot rescue a weak company.
Weak communication can absolutely slow down a strong one.
Recruit Operators Earlier
Scientific founders often need commercial partners.
An exceptional research team should not wait until late stages to add people who understand sales, partnerships, product, operations, and company building.
Boston has enough raw innovation.
It needs more systems for turning that innovation into large organizations.
What San Francisco Founders Can Learn From Boston
There are lessons in the opposite direction too.
Domain Expertise Is a Moat
The ability to call a foundation model through an API is not a durable advantage.
Understanding an industry better than competitors can be.
Boston’s strongest AI companies show the value of putting scientists, clinicians, engineers, and industry experts beside machine-learning teams.
Difficult Problems Can Be Better Businesses
Fast-moving horizontal categories attract enormous competition.
A problem that requires years of domain understanding may look less attractive initially.
It may also be much harder for competitors to copy.
AI Does Not Have to End at the Screen
Some of the biggest opportunities connect intelligence to laboratories, robots, clinical decisions, manufacturing systems, physical infrastructure, and scientific experiments.
Boston is particularly well positioned for that world.
What to Watch Through the Rest of 2026 and Into 2027
Several measurements will tell us whether the gap between the ecosystems is changing.
The first is Boston’s share of AI-specific venture funding.
If Boston remains around only a few percent of national AI funding while continuing to produce a large technical workforce, the commercialization gap will remain obvious.
The second is startup formation from universities.
More research becoming venture-backed companies would show that Boston is converting its educational advantage more efficiently.
The third is repeat founders.
A healthy startup ecosystem becomes much stronger when people from one successful generation begin creating the next.
The fourth is AI-company office growth.
CBRE’s data already shows Boston as one of America’s largest AI office markets outside the Bay Area and Manhattan. Continued expansion would be a useful signal that companies are scaling locally rather than moving elsewhere.
The fifth is sector diversity.
Boston’s AI ecosystem becomes more resilient if it expands beyond science and health while retaining those strengths.
Basis and newer agent companies are early evidence that this may be happening.
BostonBizScene Original Research Summary
The data tells six clear stories.
| Original Finding | Result |
| Capital scale | Bay Area Q2 2026 VC value was 19.3× Boston’s |
| Deal breadth | Bay Area had only 3.77× Boston’s deal count |
| Capital intensity | Bay Area deal value per reported deal was 5.13× Boston’s |
| Growth pattern | Boston deal count grew faster; Bay Area deal value grew dramatically faster |
| Talent | Bay Area AI workforce was 3.59× Boston’s |
| Talent cost | Bay Area tech wages were about 48.9% higher |
| AI specialization | Bay Area AI fundraising share over-indexed its overall funding footprint by about 29% |
| Boston AI funding | Boston under-indexed in broad AI funding relative to overall venture activity |
| Boston biotech specialization | Boston biotech funding share was roughly 3.97× its overall funding share |
| Physical clustering | Bay Area AI office leasing was about 5.7× Boston’s |
The important thing is how these measurements fit together.
San Francisco’s advantage becomes larger as a company moves toward capital-intensive, horizontal, software-driven AI.
Boston’s relative advantage becomes stronger as a company moves toward scientifically difficult, industry-specific, research-heavy AI.
That is the clearest difference between the ecosystems.
The Bigger Story: Boston and San Francisco Are Building Two Different Versions of the AI Economy
The easiest way to compare Boston and San Francisco is to count dollars.
San Francisco wins that comparison by an enormous margin.
But dollars alone do not explain why companies form where they do.
San Francisco has become the center of gravity for the current AI software boom because talent, capital, frontier models, venture investors, successful founders, customers, and rapidly growing startups all sit unusually close together.
The system moves extremely quickly.
Boston moves differently.
It has less AI venture capital and fewer AI specialists, but it combines world-class computing research with biology, medicine, robotics, engineering, universities, hospitals, laboratories, and companies that already spend billions solving difficult technical problems.
Those assets create a different kind of opportunity.
The most important question for Boston is not whether it can become another San Francisco.
It probably should not try.
The opportunity is to become the strongest place in the world for building AI that has to understand something deeper than software.
AI that understands biology.
AI that works inside hospitals.
AI that designs experiments.
AI that controls machines.
AI that helps engineers.
AI that works inside regulated businesses.
AI that handles difficult professional workflows.
AI that connects digital intelligence with the physical and scientific world.
San Francisco currently has the much larger AI startup machine.
Boston has many of the ingredients required to build a very different one.
If Boston can connect its research strength with faster company formation, stronger commercialization, more repeat founders, deeper venture networks, and greater ambition, the gap in AI startup funding does not have to define the ecosystem.
The better way to understand the two cities is therefore not Boston versus San Francisco as substitutes.
It is San Francisco as America’s great AI scale engine, and Boston as a potential AI application and scientific commercialization engine.
In the next phase of AI, both could matter enormously.
They may simply matter for very different reasons.
